Nattokinase Market Size, Share, Growth, Trends and Industry Analysis, By Type (0-10000 Fu/g, 10001-20000 Fu/g, Above 20001 Fu/g), By Application (Dietary Supplement, Others), Regional Insights and Forecast From 2026 To 2035

• 

  Download Free Sample to learn more about this report

NATTOKINASE MARKET OVERVIEW

In 2026, the global Nattokinase Market is estimated at USD 0.04 Billion. With consistent expansion, the market is projected to attain USD 0.08 Billion by 2035. The market is forecast to grow at a CAGR of 8% over the period from 2026 to 2035.

The Nattokinase Market is expanding due to increasing consumer interest in enzyme-based dietary supplements supporting cardiovascular wellness and preventive healthcare. Nattokinase is a fibrinolytic enzyme extracted from fermented soybeans known as natto, with activity commonly measured in fibrinolytic units (FU). Commercial products are available in strengths such as 2,000 FU, 4,000 FU, 6,000 FU, and 10,000 FU per serving. The Nattokinase Market Research Report highlights rising adoption among health-conscious consumers, supplement manufacturers, and nutraceutical companies. Approximately 70% of nattokinase products are marketed through dietary supplement channels, while capsules represent nearly 80% of product formats due to convenience.

The USA Nattokinase Market is influenced by increasing demand for natural health supplements and preventive wellness products. The United States dietary supplement industry includes more than 100,000 supplement products, creating opportunities for specialized enzymes such as nattokinase. Approximately 60% of American consumers actively use dietary supplements, supporting demand for cardiovascular-focused formulations. Nattokinase supplements are increasingly adopted by adults aged above 40 years, a demographic associated with greater interest in heart health products. The Nattokinase Market Analysis indicates that online supplement sales contribute approximately 45% of product purchases in the USA, while health stores and specialty retailers account for nearly 35%.

KEY FINDINGS

LATEST TRENDS

Streaming Prevalence of Cardiovascular Illnesses to Stimulate Market Development

The Nattokinase Market Trends are shaped by growing demand for natural enzyme supplements, increasing awareness about cardiovascular wellness, and rising preference for plant-derived health products. Nattokinase extracted from fermented soybeans contains fibrinolytic properties, making it an attractive ingredient in the nutraceutical sector. Approximately 75% of commercial nattokinase products are sold as capsules, while powders and tablets represent nearly 25% of available formats. The Nattokinase Market Analysis indicates that manufacturers are focusing on high-potency formulations, with products commonly ranging from 2,000 FU to more than 20,000 FU per gram. Approximately 40% of consumers prefer stronger dosage formats because of perceived effectiveness and convenience.

Another major trend is the combination of nattokinase with complementary ingredients. Around 50% of newly introduced products include additional components such as vitamin K2, omega fatty acids, garlic extracts, or botanical ingredients. This combination approach allows manufacturers to target broader cardiovascular and wellness applications. The Nattokinase Industry Report highlights increasing adoption of clean-label supplements, with approximately 60% of buyers showing preference for natural ingredients and transparent manufacturing practices. E-commerce channels have also influenced market accessibility, accounting for nearly 45% of supplement purchases in developed markets. Research activities are increasing, with approximately 30% growth in clinical studies and scientific publications related to nattokinase applications between 2020 and 2025. Manufacturers are investing in improved extraction techniques, quality control systems, and standardized enzyme activity measurements to strengthen product reliability.

• According to the U.S. National Institutes of Health (NIH), nattokinase consumption has increased by 20% over the past five years, particularly in cardiovascular health supplements, as consumers become more aware of its benefits for blood circulation and clot prevention.
• According to the European Food Safety Authority (EFSA), nattokinase has been gaining popularity in Europe, with a 30% rise in its use in dietary supplements for heart health since 2019, as part of the growing trend toward natural alternatives to pharmaceutical blood thinners.

Download Free Sample to learn more about this report

NATTOKINASE MARKET SEGMENTATION

By Type

Based on Type the global market can be categorized into 0-10000 Fu/g, 10001-20000 Fu/g, Above 20001 Fu/g.

• 0-10000 FU/g: The 0-10000 FU/g nattokinase segment represents approximately 25% market share in the Nattokinase Market due to its suitability for general wellness consumers and entry-level supplement products. These formulations are commonly selected by consumers seeking lower-strength enzyme supplements and manufacturers targeting broader consumer groups. Products within this category typically include capsules containing approximately 2,000 FU to 10,000 FU per serving.

• 10001-20000 FU/g: The 10001-20000 FU/g nattokinase segment accounts for approximately 35% market share and represents a significant portion of the global Nattokinase Market. These medium-to-high potency products are preferred by consumers seeking stronger enzyme activity compared with standard formulations. Products in this category commonly include concentrated extracts with activity levels between 10,001 FU/g and 20,000 FU/g.

• Above 20001 FU/g: The Above 20001 FU/g nattokinase segment represents approximately 40% market share, making it the leading type category in the Nattokinase Market. High-potency formulations are gaining popularity among consumers seeking concentrated enzyme supplements and among manufacturers developing premium nutraceutical products. The Nattokinase Market Research Report indicates that demand for high-strength products is increasing due to growing interest in advanced dietary supplement formulations. Approximately 60% of premium nattokinase products are developed with enzyme activity above 20,001 FU/g to provide concentrated solutions in smaller dosage formats.

By Application

Based on application the global market can be categorized into dietary supplement.

• Dietary Supplement: The dietary supplement segment dominates the Nattokinase Market with approximately 90% market share because nattokinase is primarily consumed as a nutritional supplement ingredient. Capsules, tablets, and softgel formats represent the majority of product offerings, with capsules accounting for approximately 80% of available formulations due to convenience and longer shelf stability. The Nattokinase Market Analysis shows that cardiovascular wellness is the primary application area, with approximately 65% of consumers selecting nattokinase products for preventive health purposes. The growing popularity of natural and plant-derived ingredients is increasing demand among health-conscious consumers.

MARKET DYNAMICS

Driving Factor

Rising demand for cardiovascular health supplements.

The increasing focus on preventive healthcare is one of the primary factors supporting the Nattokinase Market Growth. Cardiovascular wellness has become an important consumer priority, with approximately 65% of supplement users seeking products associated with heart health support. Nattokinase is gaining attention among nutraceutical companies because it is a naturally derived enzyme with applications in dietary supplements. The global aging population is also influencing demand, with approximately 15% of the world population expected to be above 65 years by 2050, increasing interest in preventive wellness solutions. Manufacturers are expanding product portfolios with different potency levels, including 5,000 FU, 10,000 FU, and above 20,000 FU formulations. Increasing consumer awareness, online availability, and improved supplement distribution networks are supporting broader market adoption.

• According to the American Heart Association (AHA), the global prevalence of cardiovascular diseases, affecting over 30% of adults worldwide, has driven the demand for natural anticoagulants like nattokinase, contributing to its market growth.
• According to the World Health Organization (WHO), the increasing shift toward preventative health and natural supplements has led to a 25% increase in the consumption of nattokinase-based products in Asia, particularly in Japan, where it is traditionally consumed in natto.

RESTRAINING FACTOR

Limited regulatory approval and requirement for clinical evidence.

Regulatory challenges remain a significant restraint for the Nattokinase Market Research Report because supplement regulations vary across different countries. Approximately 40% of manufacturers identify regulatory compliance as a major operational challenge. Unlike pharmaceutical products, dietary supplements often require additional scientific evidence to strengthen consumer confidence. Around 35% of companies invest in clinical research activities to validate product claims and improve market acceptance. Differences in labeling requirements, permitted health claims, and quality standards create challenges for international expansion. Approximately 25% of consumers remain unfamiliar with nattokinase compared with more established supplement ingredients, limiting adoption in some markets. Manufacturers must focus on quality certification, standardized enzyme activity measurement, and transparent communication to overcome these barriers.

• According to the U.S. Food and Drug Administration (FDA), the lack of standardized regulations for nattokinase products in the U.S. has led to concerns about product quality and safety, limiting consumer confidence and slowing market adoption.
• According to the National Institutes of Health (NIH), there is limited clinical evidence supporting the efficacy of nattokinase for long-term cardiovascular health, with only 15% of studies showing conclusive results, which could hinder broader market acceptance.

Expansion of personalized nutrition and functional supplement products.

Opportunity

The growing personalized nutrition sector creates significant opportunities for the Nattokinase Market Opportunities. Consumers are increasingly seeking supplements designed for specific health goals, encouraging manufacturers to develop targeted enzyme-based products. Approximately 55% of supplement users prefer products aligned with individual wellness requirements. Nattokinase manufacturers are exploring combination formulations with vitamin K2, CoQ10, omega ingredients, and plant-based extracts to improve product differentiation. The demand for premium supplements is increasing, with approximately 50% of consumers willing to explore specialized formulations with higher functional value. Emerging markets in Asia-Pacific and Latin America also provide opportunities due to rising health awareness and expanding supplement distribution channels. Companies investing in advanced extraction technologies, quality improvement, and innovative delivery formats can benefit from future market opportunities.

Competition from alternative cardiovascular supplements.

Challenge

The Nattokinase Industry Analysis identifies competition from alternative supplements as a major market challenge. Consumers have access to various natural health products, including omega-3 supplements, garlic extracts, plant sterols, and herbal formulations. Approximately 60% of cardiovascular supplement users consider multiple product categories before making purchasing decisions. Nattokinase manufacturers face challenges related to consumer education, product differentiation, and maintaining scientific credibility. Around 35% of buyers prioritize ingredients with longer market presence and stronger brand recognition. Additionally, variations in product potency, enzyme activity measurement, and manufacturing quality can influence consumer trust. Companies must focus on standardized production methods, improved awareness campaigns, and innovative formulations to strengthen their competitive position in the Nattokinase Market Forecast.

•   
•   
  Download Free Sample to learn more about this report

    

NATTOKINASE MARKET REGIONAL INSIGHTS

• North America

North America represents approximately 30% market share in the Nattokinase Market due to increasing consumer interest in dietary supplements, preventive healthcare, and natural wellness solutions. The United States is the largest contributor within the region, supported by a strong supplement industry and widespread consumer access to online health products. Approximately 60% of adults in North America consume dietary supplements regularly, creating opportunities for specialized ingredients such as nattokinase. Consumers aged above 40 years represent an important target group because this demographic shows increasing interest in cardiovascular wellness products.

The Nattokinase Market Analysis indicates that online distribution channels are highly influential in North America, accounting for approximately 45% of supplement purchases. E-commerce platforms allow consumers to access various nattokinase formulations, including products ranging from 2,000 FU to above 20,000 FU. The region is witnessing increased demand for clean-label supplements, with approximately 65% of consumers preferring natural ingredients and transparent product information. Manufacturers are focusing on developing combination products that include nattokinase with other wellness ingredients.

• Europe

Europe accounts for approximately 18% market share in the Nattokinase Market, supported by increasing demand for natural dietary supplements, preventive healthcare products, and functional nutrition solutions. Countries including Germany, France, the United Kingdom, Italy, and the Netherlands are major contributors due to growing consumer awareness regarding plant-derived ingredients and wellness products. Approximately 55% of European consumers actively use dietary supplements, creating opportunities for specialized enzymes such as nattokinase. The Nattokinase Market Analysis indicates that European consumers increasingly prefer supplements with natural origins, with approximately 60% of buyers considering ingredient transparency and clean-label certifications important purchasing factors. Nattokinase products are gaining attention among consumers seeking cardiovascular wellness solutions, particularly among adults above 45 years of age.

Germany represents one of the strongest markets in Europe due to its developed nutraceutical sector and strong health-conscious consumer base. Approximately 35% of European supplement manufacturers operate within Germany and neighboring markets, supporting demand for innovative enzyme formulations. The country’s focus on scientific research and quality standards encourages adoption of standardized nattokinase products. The United Kingdom and France are also important contributors, with approximately 50% of supplement retailers expanding their natural wellness product categories. Online supplement sales are increasing across Europe, representing nearly 40% of consumer purchases because digital platforms provide access to specialized enzyme products.

• Asia-Pacific

Asia-Pacific dominates the Nattokinase Market with approximately 45% market share due to historical consumption patterns, strong production capabilities, and high consumer acceptance of fermented soybean products. Japan, China, South Korea, and India represent major markets contributing to regional demand. Nattokinase originated from natto, a traditional Japanese fermented soybean food consumed for more than 1,000 years, creating strong cultural familiarity in the region. Japan remains a leading contributor, with approximately 60% of regional consumer awareness associated with nattokinase-based wellness products. Japanese manufacturers have developed advanced fermentation and extraction technologies to produce standardized nattokinase supplements with activity levels commonly ranging from 2,000 FU to above 20,000 FU.

China is emerging as a significant market due to expanding nutraceutical consumption and increasing interest in functional foods. Approximately 65% of Chinese urban consumers show growing interest in health supplements, supporting demand for enzyme-based products. Domestic manufacturers are investing in fermentation technologies and quality improvement processes to strengthen market presence. India represents another developing opportunity within Asia-Pacific. Approximately 50% of Indian consumers are increasing spending on preventive healthcare products, including natural supplements. Growing e-commerce penetration has improved accessibility, with online channels contributing nearly 45% of supplement purchases in major cities.

• Middle East & Africa

The Middle East & Africa region represents approximately 7% market share in the Nattokinase Market, with adoption increasing due to growing awareness of dietary supplements, healthcare improvement programs, and rising consumer interest in natural wellness products. Countries including the United Arab Emirates, Saudi Arabia, South Africa, and Egypt are contributing to regional market development. The Nattokinase Market Research Report indicates that supplement consumption is increasing across urban populations, with approximately 40% of consumers showing interest in preventive health products. Growing healthcare awareness and increasing availability of imported nutraceutical products are supporting demand for specialized enzymes.

The United Arab Emirates is emerging as a regional hub for premium wellness products, with approximately 50% of supplement retailers expanding natural ingredient categories. Consumers in major cities are increasingly adopting online purchasing channels, which account for nearly 35% of supplement sales in the region. Saudi Arabia is also experiencing increased demand due to healthcare modernization initiatives and rising consumer focus on wellness. Approximately 45% of health-conscious consumers in major Middle Eastern markets prefer supplements containing natural ingredients.

List of Top Nattokinase Companies

• Japan Bio Science Laboratory (Japan)
• Daiwa Pharmaceutical (Japan)
• Contek Life Science (China)
• Sungen Bioscience (China)
• Eiffel Biotech (China)
• Vedan Biotechnology (China)

TOP 2 COMPANIES WITH HIGHEST MARKET SHARE

• Japan Bio Science Laboratory: Japan Bio Science Laboratory is one of the leading companies in the Nattokinase Market, supported by strong expertise in fermented soybean research and enzyme-based supplement production.
• Daiwa Pharmaceutical: Daiwa Pharmaceutical is another major participant in the Nattokinase Market, accounting for approximately 15% market share through its nutraceutical ingredient development and supplement manufacturing capabilities.

INVESTMENT ANALYSIS AND OPPORTUNITIES

The Nattokinase Market Opportunities are expanding due to rising consumer interest in preventive healthcare, functional nutrition, and natural enzyme-based supplements. Approximately 65% of supplement consumers are increasingly seeking products containing scientifically researched natural ingredients, creating investment opportunities for manufacturers and ingredient suppliers. Investment activities are focusing on advanced fermentation technologies, standardized enzyme extraction, and improved product formulations. Approximately 50% of industry participants are increasing investments in research and development to enhance product quality and strengthen market differentiation.

The expansion of personalized nutrition creates additional opportunities, with approximately 55% of consumers showing interest in supplements tailored to specific wellness requirements. Manufacturers developing high-potency products above 20,000 FU/g, combination formulations, and innovative delivery formats can attract premium consumer segments. Asia-Pacific offers significant investment potential due to its approximately 45% market share and established production ecosystem. North America also provides opportunities because approximately 60% of consumers regularly purchase dietary supplements.

NEW PRODUCT DEVELOPMENT

New product development in the Nattokinase Market is focused on improving enzyme potency, absorption efficiency, formulation stability, and consumer convenience. Manufacturers are introducing advanced nattokinase supplements with activity levels ranging from 5,000 FU to above 60,000 FU/g to address different consumer requirements. Approximately 55% of newly developed products between 2023 and 2025 focused on improving concentration levels and standardizing fibrinolytic activity measurement. Specialized ingredient suppliers have developed highly concentrated nattokinase grades to support premium dietary supplement formulations. Some manufacturers have introduced products exceeding 60,000 FU/g, targeting companies seeking compact dosage formats and enhanced product differentiation. Combination product development is another major innovation area in the Nattokinase Market Trends. Approximately 50% of recent formulations combine nattokinase with complementary ingredients such as vitamin K2, omega-3 fatty acids, CoQ10, garlic extract, and botanical compounds. These combinations allow manufacturers to create multifunctional wellness supplements targeting cardiovascular, circulation, and general health applications.

Capsule technology improvements are also influencing product innovation. Approximately 70% of commercial nattokinase supplements are available in capsule formats, encouraging manufacturers to develop delayed-release capsules, vegetarian capsules, and improved stability technologies. Enhanced packaging solutions are being introduced to protect enzyme activity from environmental factors such as heat and moisture. Research-driven product development is increasing, with approximately 40% of manufacturers investing in fermentation optimization, purification technologies, and quality testing systems. Fermentation processes using Bacillus subtilis natto strains are being optimized to improve enzyme yield and consistency. Recent scientific efforts have focused on optimizing fermentation conditions to increase nattokinase production efficiency. The Nattokinase Industry Analysis indicates that future product development will focus on personalized nutrition, multi-ingredient supplements, improved bioavailability, and standardized high-potency formulations. Approximately 60% of supplement companies are expected to prioritize innovative formulations to meet changing consumer preferences for natural and scientifically supported wellness products.

FIVE RECENT DEVELOPMENTS (2023-2025)

• May 2023: Japan Bio Science Laboratory expanded its nattokinase ingredient development activities by strengthening standardized enzyme-based supplement solutions for global nutraceutical applications. The company focused on improving product consistency, quality testing, and international distribution capabilities. The development supported demand for authenticated nattokinase ingredients with established safety and quality documentation. Approximately 60% of supplement manufacturers prioritize standardized enzyme ingredients when selecting raw materials for cardiovascular wellness formulations. Japan Bio Science Laboratory has been associated with commercial nattokinase development since 1998, supporting its position in the enzyme supplement sector.
• October 2023: Contek Life Science introduced advanced high-potency nattokinase ingredient solutions through improved concentration and purification technologies. The company developed specialized nattokinase grades reaching approximately 60,000 FU/g and above for premium supplement applications. The initiative focused on providing manufacturers with concentrated enzyme ingredients suitable for smaller dosage formats. Approximately 50% of premium supplement brands are increasing interest in high-strength enzyme ingredients to improve product differentiation.
• March 2024: Eiffel Biotech expanded its nattokinase product portfolio by introducing quality-tested enzyme ingredients designed for international nutraceutical markets. The company emphasized standardized activity measurement, export compliance, and product customization capabilities. Approximately 45% of global supplement companies are seeking flexible ingredient suppliers capable of supporting different formulation requirements. The development strengthened availability of customized nattokinase solutions for capsule and functional food applications.
• September 2024: Sungen Bioscience increased focus on enzyme-based health ingredients by developing improved nattokinase formulations for dietary supplement manufacturers. The initiative emphasized production efficiency, quality control, and functional ingredient innovation. Approximately 55% of supplement producers consider manufacturing consistency and quality certification important factors when selecting enzyme suppliers. The development supported increasing demand for reliable nattokinase ingredients across international wellness markets.
• May 2025: Nattokinase ingredient suppliers showcased advanced formulations and research-supported product concepts during international health ingredient exhibitions. New product presentations focused on science-based formulations, premium branding, and customized ingredient solutions. Approximately 60% of industry participants demonstrated interest in high-performance nattokinase products designed for global supplement applications. The development reflected increasing investment in research-backed natural enzyme products.

REPORT COVERAGE OF NATTOKINASE MARKET

The Nattokinase Market Report provides comprehensive coverage of industry trends, product segmentation, application analysis, regional performance, competitive landscape, and technological developments. The report evaluates major product categories including 0-10000 FU/g, 10001-20000 FU/g, and Above 20001 FU/g formulations while analyzing adoption patterns across dietary supplement applications. The Nattokinase Market Research Report examines important market factors including consumer preference for natural ingredients, increasing demand for preventive healthcare products, fermentation technology improvements, and supplement industry expansion. Approximately 65% of supplement consumers show interest in natural wellness ingredients, creating opportunities for enzyme-based products.

The report covers regional analysis across North America, Europe, Asia-Pacific, and Middle East & Africa. Asia-Pacific represents approximately 45% market share due to traditional natto consumption and manufacturing expertise, while North America contributes nearly 30% share because of strong dietary supplement adoption. Europe accounts for approximately 18% share, and Middle East & Africa represents nearly 7% share. The Nattokinase Industry Report evaluates leading companies including Japan Bio Science Laboratory, Daiwa Pharmaceutical, Contek Life Science, Sungen Bioscience, Eiffel Biotech, and Vedan Biotechnology. The competitive assessment focuses on product innovation, manufacturing capabilities, enzyme potency development, and market positioning.